Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal

Weight loss is one of the hardest parts of pancreatic cancer: a review in the journal Cancers reported that more than 80% of patients have significant weight loss by the time they are diagnosed. Part of the reason is that the pancreas does more than make insulin. It also makes the enzymes your gut needs to break down food, and when a tumor or surgery gets in the way, much of what you eat can pass through without being absorbed. Pancreatic enzyme replacement therapy, often called PERT, is a simple, long-used treatment for that problem, yet many patients are not told about it until well into their care. Here is how it works and how to get the most out of it during Pancreatic Cancer Awareness Month and beyond.

Why Food Stops Being Absorbed

The pancreas releases enzymes into the small intestine that break fat, protein and carbohydrates into pieces small enough to absorb. A tumor can block the duct that carries those enzymes, and surgery such as the Whipple procedure removes part of the pancreas, so many people with pancreatic cancer do not make enough. Doctors call this pancreatic exocrine insufficiency.

The signs are often mistaken for side effects of chemotherapy or for the cancer itself. They include bloating, gas, stomach cramps, diarrhea and stools that are pale, oily, float or are hard to flush, along with weight loss even when you are eating. Pancreatic Cancer UK, a patient charity, notes in its guidance that most people with pancreatic cancer will need enzyme replacement, and that those who do usually take it for the long term because the pancreas does not start making enzymes again.

How the Capsules Work

PERT capsules contain the same kinds of enzymes the pancreas makes, taken from pig pancreas. In the U.S., the FDA-approved products include Creon, Zenpep, Pancreaze, Pertzye and Viokace, all forms of pancrelipase. The capsules do their job only when they are in the gut at the same time as food, which is why the timing of each dose matters as much as the dose.

Taking Them With Every Meal and Snack

Enzymes are taken with meals and with snacks, including milky drinks, not once or twice a day like many pills. Larger meals, meals higher in fat and meals eaten slowly generally need more capsules, while a small snack may need fewer. According to the Creon prescribing information, the capsules should be swallowed whole with enough liquid, not crushed or chewed. If swallowing them is hard, the contents can be sprinkled onto a spoonful of an acidic soft food such as applesauce and swallowed right away.

Dosing is individual. Your care team or a dietitian will usually start you on a set number of capsules per meal and adjust based on your symptoms, your stools and your weight. If you are still bloated or losing weight, it is worth telling them, because the dose may need to go up or the timing may need to change rather than the enzymes simply not working.

Side Effects and Safety Points

Most people tolerate enzymes well. In adults who had part of the pancreas removed or had chronic pancreatitis, the most common side effects in the Creon label were changes in blood sugar, stomach pain, unusual stools, gas, more frequent bowel movements and cold-like symptoms. Very high doses have been linked to a rare narrowing of the colon and to higher uric acid levels, which is one reason not to raise your dose on your own. Because the enzymes come from pigs, people with pork allergies or religious or dietary concerns should raise this with their care team.

Bringing It Up at Your Next Visit

If you have pancreatic cancer and nobody has mentioned enzymes, or you have digestive symptoms that have not improved, ask whether PERT is right for you and whether you can see a dietitian who works with cancer patients. People with diabetes should also ask how enzymes and changes in eating might affect blood sugar. For a broader overview of the disease and its treatment, see CURE's pancreatic cancer basics.

References

1. "Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer." Cancers (Basel). Jan. 22, 2020.
2. "CREON (pancrelipase) delayed-release capsules, full prescribing information." AbbVie. Revised February 2024.
3. "Pancreatic enzyme replacement therapy (PERT) for pancreatic cancer." Pancreatic Cancer UK. Updated May 2026.

For more news on cancer updates, research and education, don't forget to subscribe to CURE®'s newsletters here.